TipRanks
Gilead Sciences (CH:GILD)
:GILD
Switzerland Market
GILD
Gilead Sciences
RESEARCH TOOLSreports

Gilead Sciences (GILD) Stock News & Sentiment

4 Followers
Michael Yee Reiterates Buy on Gilead, Highlighting Yeztugo-Driven HIV Growth and Maintaining Unchanged $175 Price Target
Premium
Ratings
Michael Yee Reiterates Buy on Gilead, Highlighting Yeztugo-Driven HIV Growth and Maintaining Unchanged $175 Price Target
11d ago
GILD
3 Best ETFs Offering 10%+ Upside, Picked by AI Analyst
Premium
Market News
3 Best ETFs Offering 10%+ Upside, Picked by AI Analyst
15d ago
VZ
BMY
Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst
Premium
Company Announcements
Gilead’s Arcus-Backed Cancer Trial Reaches Completion, Setting Up a Key Immuno-Oncology Catalyst
1M ago
GILD
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
Premium
Market News
Gilead Sciences Stock (GILD) Slips 2% Despite FDA Approval of Bixlenvo
1M ago
GILD
Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
Premium
Market News
Tempus AI Stock (TEM) Is Surging 24% on Wednesday – Here’s Why
2M ago
MRK
TEM
Gilead Sciences Earnings Call Highlights Strong Core Growth
Premium
Company Announcements
Gilead Sciences Earnings Call Highlights Strong Core Growth
2M ago
GILD
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
Premium
Ratings
Gilead: Strong HIV and Oncology Growth Underpins Reiterated Buy Rating and Unchanged $165 Price Target
2M ago
GILD
More CH:GILD News >

GILD News on the Web

Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
Zacks
Neutral
Gilead Sciences (GILD) Chairman & CEO Daniel O'day Sells 15,000 Shares
GuruFocus News
Neutral
Gilead put volume heavy and directionally bearish
TipRanks News
Neutral
Gilead or Johnson & Johnson: Is Faster Growth Better than Greater Diversification?
Insider Monkey
Neutral
Gilead’s HIV Concentration or Pfizer’s Patent Cliff: Which Risk is Easier to Own?
Insider Monkey
Bullish
Gilead vs. Medtronic: Which Healthcare Stock Offers the Better Mix of Growth and Income?
Insider Monkey
Neutral
Why Morgan Stanley likes Gilead's HIV prevention play
TheStreet.com
Bullish
Gilead Sciences (GILD) -- Innovation in Biopharma | BNY Mellon Global Equity Income Fund Q2 2026
GuruFocus News
Neutral

News Score - Last 7 Days

Neutral
CH:GILD
Sector Average
Media Buzz
This Week14 articles
Weekly Average13.25 articles
News Sentiment
This Week50%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CH:GILD’s Media Buzz Sentiment?
14 articles about CH:GILD were published this week. In an average week, 13.25 articles are published.
    What is CH:GILD’s weekly average amount of articles?
    In an average week, 13.25 articles about CH:GILD are published.
      What is CH:GILD’s News Sentiment?
      50% of articles about CH:GILD were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XERSXeris Pharmaceuticals
        QTTBQ32 Bio
        ABTAbbott Laboratories
        GMABGenmab
        BAYRYBayer
        Showing the stocks with the most bullish news sentiment over the past week